trending Market Intelligence /marketintelligence/en/news-insights/trending/C8vwL6_LFGaYgr7ZlxaW0w2 content esgSubNav
In This List

Alkermes appoints chief medical officer

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Alkermes appoints chief medical officer

Craig Hopkinson will become Alkermes plc's chief medical officer on Feb. 1, 2018.

He will be joined by Mark Namchuk, who will serve as senior vice president of research, pharmaceutical and non-clinical development, to assume all leadership responsibilities for the company's research and development organization.